Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Michael Aaron Kelly Insider Profile

4 Followers

Michael Aaron Kelly, Director at Prime Medicine, Inc., holds ― shares in Prime Medicine, Inc. (Ticker: PRME), holds 72.09K shares in NeoGenomics (Ticker: NEO), holds 65.59K shares in DMC Global (Ticker: BOOM).

Michael Aaron Kelly's Trading History

NEONeoGenomics		Jun 03, 2026DirectorUninformative Buy240.92K$1.25M
BOOMDMC Global		May 14, 2026DirectorUninformative Buy―$613.27K
FOLDAmicus		Apr 27, 2026―Uninformative Sell1.05M$0.00
APREAprea Therapeutics		Jul 01, 2021DirectorUninformative Buy―$2.23K
HOOKHookipa Pharma		Oct 23, 2020―Uninformative Buy―$6.62K
PRMEPrime Medicine, Inc.		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Michael Aaron Kelly insider profile FAQ

What stocks does Michael Aaron Kelly hold?
Michael Aaron Kelly holds: PRME, FOLD, BOOM, NEO, HOOK, APRE stocks.
What is Michael Aaron Kelly's role in Prime Medicine, Inc.?
Michael Aaron Kelly's role in Prime Medicine, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.